Nuclear processes and oncogenes

LDR 01800nam a2200433 a 4500
001 002584275
003 MiAaHDL
005 20221205000000.0
006 m d
007 cr bn ---auaua
008 921215s1992 caua b 101 0 eng c
010 ‡a91041218
020 ‡a0126390258 ‡q(alk. paper)
035 ‡a(MiU)990025842750106381
035 ‡asdr-miu.990025842750106381
035 ‡z(MiU)MIU01000000000000002584275-goog
035 ‡a(OCoLC)24796103
035 ‡z(MiU)Aleph002584275
040 ‡aDNLM/DLC ‡cDLC ‡dNLM ‡dEYM
050 0 0 ‡aRC268.42 ‡b.N84 1992
060 0 ‡aW1 ‡bBR324 v.14 1992 ‡a[QZ 202 N965 1990]
082 0 0 ‡a616.99/2042 ‡220
245 0 0 ‡aNuclear processes and oncogenes / ‡cedited by Phillip A. Sharp.
260 ‡aSan Diego : ‡bAcademic Press, ‡cc1992.
300 ‡axx, 216 p. : ‡bill. ; ‡c24 cm.
490 0 ‡aBristol-Myers Squibb cancer symposia ; ‡v14
500 ‡aBased on the 14th Bristol-Myers Squibb Symposia on Cancer Research, held on Sept. 24, 1990 at Massachusetts Institute of Technology.
504 ‡aIncludes bibliographical references and index.
538 ‡aMode of access: Internet.
650 2 ‡aSignal Transduction ‡xcongresses.
650 2 ‡aOncogenes ‡xcongresses.
650 2 ‡aNuclear Proteins ‡xgenetics ‡xcongresses.
650 2 ‡aNeoplasms ‡xgenetics ‡xcongresses.
650 2 ‡aGene Expression Regulation ‡xcongresses.
650 2 ‡aCell Transformation, Neoplastic ‡xcongresses.
650 0 ‡aGenetic transcription ‡xRegulation ‡xCongresses.
650 0 ‡aGene expression ‡vCongresses.
650 0 ‡aAntioncogenes ‡xCongresses.
650 0 ‡aOncogenes ‡vCongresses.
700 1 ‡aSharp, Phillip A.
711 2 ‡aBristol-Myers Squibb Symposium on Cancer Research ‡n(14th : ‡d1990 : ‡cMassachusetts Institute of Technology)
899 ‡a39015028434390
CID ‡a002584275
DAT 0 ‡a19921215000000.0 ‡b20221205000000.0
DAT 1 ‡a20221207060734.0 ‡b2023-11-18T18:44:22Z
CAT ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008
FMT ‡aBK
HOL ‡0sdr-miu.990025842750106381 ‡aMiU ‡bSDR ‡cMIU ‡f002584275 ‡pmdp.39015028434390 ‡sMIU ‡1990025842750106381
974 ‡bMIU ‡cMIU ‡d20231118 ‡sgoogle ‡umdp.39015028434390 ‡y1992 ‡ric ‡qbib ‡tUS bib date1 >= 1929